LPB Combined with QLB Using Single-needle Technique (LPQLB-SNT) for Hip Arthroplasty
NCT ID: NCT04266236
Last Updated: 2025-02-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2020-07-09
2024-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lumbar Plexus vs Quadratus Lumborum Block in Post-operative Pain Following Total Hip Replacement
NCT03801265
QL vs LP Blocks for Analgesia Following THA
NCT04402437
Lumbar Plexus and Suprainguinal Fascia Iliaca Blocks For Total Hip Replacement
NCT03744065
Analgesia in Total Hip Arthroplasty by Quadratus Lumborum Block
NCT03666260
Continuous Lumbar Plexus Block for Postoperative Pain Control After Total Hip Arthroplasty
NCT00790179
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
L3 LPB technique (P group)
ultrasound-guided shamrock approach L3 lumbar plexus block with single-needle technique
L3 LPB
ultrasound-guided L3 lumbar plexus block
0.375%ropivacaine 25 ml (Raropin)
0.375%ropivacaine (Raropin) 25ml will be given
General anesthesia with tracheal intubation
General anesthesia with tracheal intubation will be induced with sufentanil, propofol, vecuronium for every patient before the operation and maintained with sevoflurane during the operation
T12 combined with L3 and L4 LPB technique (TP group)
ultrasound-guided posterior approach thoracic 12 combined with L3 and L4 lumbar plexus block with mulitple-needle technique
L3 LPB
ultrasound-guided L3 lumbar plexus block
L4 LPB
ultrasound-guided L4 lumbar plexus block
T12 block
ultrasound-guided thoracic 12th segment nerve block
0.375%ropivacaine 40 ml (Raropin)
0.375%ropivacaine (Raropin) 40ml will be given
General anesthesia with tracheal intubation
General anesthesia with tracheal intubation will be induced with sufentanil, propofol, vecuronium for every patient before the operation and maintained with sevoflurane during the operation
L3 LPB combined with QLB (LPQLB-SNT, PQ group)
ultrasound-guided shamrock approach L3 lumbar plexus block combined with quadratus lumborum block with single-needle technique
L3 LPB
ultrasound-guided L3 lumbar plexus block
L3 QLB
ultrasound-guided quadratus lumborum block at L3 level
0.375%ropivacaine 40 ml (Raropin)
0.375%ropivacaine (Raropin) 40ml will be given
General anesthesia with tracheal intubation
General anesthesia with tracheal intubation will be induced with sufentanil, propofol, vecuronium for every patient before the operation and maintained with sevoflurane during the operation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
L3 LPB
ultrasound-guided L3 lumbar plexus block
L4 LPB
ultrasound-guided L4 lumbar plexus block
T12 block
ultrasound-guided thoracic 12th segment nerve block
L3 QLB
ultrasound-guided quadratus lumborum block at L3 level
0.375%ropivacaine 25 ml (Raropin)
0.375%ropivacaine (Raropin) 25ml will be given
0.375%ropivacaine 40 ml (Raropin)
0.375%ropivacaine (Raropin) 40ml will be given
General anesthesia with tracheal intubation
General anesthesia with tracheal intubation will be induced with sufentanil, propofol, vecuronium for every patient before the operation and maintained with sevoflurane during the operation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. American Society of Anesthesiologists (ASA) classification I-II
3. Postero-lateral operative incision approach unilateral hip arthroplasty
4. Aged 18-75
Exclusion Criteria
2. Patients with coagulopathy or on therapeutic anticoagulation
3. Pregnancy
4. Multiple trauma
5. Hypersensitivity or allergy to ropivacaine
6. History of ankylosing spondylitis or spinal surgery
7. Lower extremity neuropathy
8. Unable to communicate
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai 6th People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiaofeng WANG
Attending doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wang X, Zhang H, Chen Y, Xie Z, Chen M, Chen Y, Zhang J. The anesthetic efficacy of ultrasound-guided lumbar plexus combined with quadratus lumborum block with Shamrock approach in total hip arthroplasty: study protocol for a randomized controlled trial. Trials. 2023 Sep 18;24(1):596. doi: 10.1186/s13063-023-07619-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.